Cargando…
Clinicopathological significance and potential drug target of T-cadherin in NSCLC
BACKGROUND: Previous studies demonstrate that T-cadherin is a candidate tumor suppressor in several types of human tumors, including non-small cell lung cancer (NSCLC). Lack of protein expression of T-cadherin by hypermethylation has been found to play an important role in lung alveolar differentiat...
Autores principales: | Wang, Zhidong, Wang, Bin, Guo, Huanchen, Shi, Guoyu, Hong, Xiuqin |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Dove Medical Press
2014
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4278732/ https://www.ncbi.nlm.nih.gov/pubmed/25565774 http://dx.doi.org/10.2147/DDDT.S74259 |
Ejemplares similares
-
Clinicopathological and prognostic significance of Twist overexpression in NSCLC
por: Li, Meng, et al.
Publicado: (2018) -
Prognostic Significance of Twist and N-Cadherin Expression in NSCLC
por: Hui, Linping, et al.
Publicado: (2013) -
Prognostic and Clinicopathological Significance of Downregulated E-Cadherin Expression in Patients with Non-Small Cell Lung Cancer (NSCLC): A Meta-Analysis
por: Yang, Yan-Long, et al.
Publicado: (2014) -
Clinicopathological significance and potential drug target of RUNX3 in breast cancer
por: Yu, Ying-Ying, et al.
Publicado: (2014) -
Clinicopathological significance of E-cadherin, β-catenin and p53 expression in gastric adenocarinoma
por: Zali, Mohammad Reza, et al.
Publicado: (2009)